NICE issues for consultation draft guideline on antibiotics for neonatal infection - NeLM

Homepage

Login | Register

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

NeLM news service

NICE issues for consultation draft guideline on antibiotics for neonatal infection

Source: NICE

Date published: 05/01/2012 17:17

Summary

by: Yuet Wan

NICE has issued a draft guideline on antibiotics for neonatal infection for consultation from the 3rd January to 27th February 2012.

About this library entry

Category: 5.1 Antibacterial drugs | Bacterial | Clinical guidelines | National Institute of Clinical Excellence (NICE) | Neonates (0-1 month)

NeLM area: News

Press release

Link to draft guideline

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.

Printer Friendly Version

Related evidence

5.1 Antibacterial drugs

14/02/2012

DTB reviews management of multidrug- and extensively drug-resistant TB

14/02/2012

SMC does not recommend aztreonam lysine (Cayston™) for pulmonary infections in cystic fibrosis

09/11/2011

Updated PRODIGY (formerly CKS) topics on gonorrhoea, pelvic inflammatory disease and scrotal swelling

Bacterial

01/04/2012

Oxygen therapy for pneumonia in adults

01/03/2012

Surfactant for bacterial pneumonia in late preterm and term infants

01/08/2011

Sublingual immunotherapy for treating allergic conjunctivitis

Neonates (0-1 month)

28/02/2012

Saline irrigation for the management of skin extravasation injury in neonates

01/04/2011

Propofol for procedural sedation/anaesthesia in neonates

04/01/2011

Vitamin A supplementation during pregnancy for maternal and newborn outcomes

Related news

5.1 Antibacterial drugs

22/05/2012

RCT: Critical pathway to reduce duration of IV antibiotic therapy and in-patient stay in community-acquired pneumonia

22/05/2012

RCT: Moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction

18/05/2012

FDA statement on risk of cardiovascular death linked to azithromycin

Bacterial

23/05/2012

HPA issues report on healthcare associated infections (HCAIs)

22/05/2012

RCT: Critical pathway to reduce duration of IV antibiotic therapy and in-patient stay in community-acquired pneumonia

22/05/2012

RCT: Moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction

Neonates (0-1 month)

18/01/2012

Data from long-term follow up of CAP trial evaluating neonatal caffeine therapy for apnoea of prematurity published

15/12/2011

FDA Drug Safety Communication on use of SSRIs during pregnancy and potential risk of persistent pulmonary hypertension of the newborn

06/10/2011

RCTs: Oral aciclovir suppression and neurodevelopment after neonatal herpes

Back